Ari Shomair
Corporate Officer/Principal chez POINT Biopharma, Inc. (United States)
Profil
Ariel Shomair is currently the Vice President of Corporate Affairs & Strategy at POINT Biopharma, Inc. in the United States.
Previously, he worked as the Chief of Staff at POINT Biopharma Global, Inc.
Postes actifs de Ari Shomair
Sociétés | Poste | Début |
---|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Corporate Officer/Principal | - |
Anciens postes connus de Ari Shomair
Sociétés | Poste | Fin |
---|---|---|
POIT BIOP | Public Communications Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
POIT BIOP | Health Technology |
Entreprise privées | 1 |
---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |